TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/25/2026
Back to search
Official data from USPTO
ONCOBETA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ONCOBETA
ST13
US500000090527069Class
5, 40, 44
Filing
90527069
Registration
7787489
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
48
Latest update
06/26/2026
Trademark type
Word
Nice classes
5, 40, 44
Filing date
02/12/2021
Registration date
05/06/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/06/2025
Last transaction
06/26/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
12/01/2024
First use in commerce
12/01/2024
Drawing code
4
Owner type
16
Owner location
88214 Ravensburg, DE
Examiner
LEE, OLIVIA SUNMIN
Law office
O10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
OncoBeta International GmbH
OncoBeta International GmbH
Representatives
Daniel P. Mullarkey Polsinelli PC
Technical classification
Nice Classes
Class 5Class 40Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for medical purposesfor use in chemotherapy; pharmaceutical preparations for the treatment of cancer; radiopharmaceutical preparations for medical purposesfor use in chemotherapy; radiopharmaceutical preparations for the treatment of cancer188-Rhenium containing preparations in the nature of sodium Re-188-perrhenate; radiopharmaceutical preparations for use in nuclear medicine; pharmaceutical preparations for use in brachytherapy and epidermal radionuclide treatment; radiopharmaceutical preparations for the treatment of skin cancer and skin lesions; radiopharmaceutical preparations for the use in cosmetic dermatology procedures
Class 40
Preparing personalized radiopharmaceutical preparations for the treatment of cancer or cosmetic usescustom manufacture of 188-Rhenium containing preparations in the nature of sodium Re-188-perrhenate by a pharmaceutical compounder
Class 44
Medical imaging servicesparticularly services in the field of radiologic and nuclear medicine; radiation therapy for the treatment of cancerin particular skin cancer and for cosmetic use; preparing personalized radiopharmaceutical preparations for the treatment of cancer or cosmetic usespharmaceutical compounding of 188-Rhenium containing preparations in the nature of sodium Re-188-perrhenate
Publications
History of USPTO decisions and trademark events.
48 publications found
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
06/25/2026
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/25/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/25/2026
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
06/25/2026
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
06/25/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/06/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
05/06/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
04/17/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
04/17/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
03/07/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
03/07/2025
IUAF
USE AMENDMENT FILED
01/06/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/06/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/06/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/06/2025
EISU
TEAS STATEMENT OF USE RECEIVED
12/30/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/18/2024
EX4G
SOU EXTENSION 4 GRANTED
06/18/2024
EXT4
SOU EXTENSION 4 FILED
06/18/2024
EEXT
SOU TEAS EXTENSION RECEIVED
06/18/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/26/2023
EX3G
SOU EXTENSION 3 GRANTED
12/22/2023
EXT3
SOU EXTENSION 3 FILED
12/22/2023
EEXT
SOU TEAS EXTENSION RECEIVED
12/22/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/27/2023
EX2G
SOU EXTENSION 2 GRANTED
06/25/2023
EXT2
SOU EXTENSION 2 FILED
06/25/2023
EEXT
SOU TEAS EXTENSION RECEIVED
06/25/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/08/2022
EX1G
SOU EXTENSION 1 GRANTED
12/06/2022
EXT1
SOU EXTENSION 1 FILED
12/06/2022
EEXT
SOU TEAS EXTENSION RECEIVED
12/06/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
06/28/2022
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
05/19/2022
DOCK
ASSIGNED TO EXAMINER
05/17/2022
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
12/06/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/09/2021
PUBO
PUBLISHED FOR OPPOSITION
11/09/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/20/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/01/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
09/17/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/17/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
09/17/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/17/2021
DOCK
ASSIGNED TO EXAMINER
09/09/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/17/2021
NWAP
NEW APPLICATION ENTERED
02/16/2021
Continuous trademark protection
Get notified about every new filing that threatens ONCOBETA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.